Thynk Capital

Thynk Capital, LLC focuses on capital-efficient, early-stage technology and life science companies with 100x return potential, primarily dedicated to extending lifespan and addressing major diseases of aging, including Alzheimer's disease, kidney disease, cancer, diabetes, and human frailty. The team consists of biotech entrepreneur investors with over 20 years of experience.